×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Walgreens Scraps Rite Aid Takeover, Will Buy Some of Its Stores Instead

Published on .

Credit: Bloomberg News

Walgreens Boots Alliance Inc. is scrapping its deal to buy all of rival Rite Aid Corp. and instead will buy a smaller piece of the drugstore chain, after the original takeover effort seemed doomed by antitrust regulators.

The companies said Thursday that they would end their original deal in which Walgreens would have bought Rite Aid for as much as $7.37 billion. Instead, Walgreens will pay $5.18 billion to buy 2,186 stores, leaving Rite Aid as a regional chain.

Although the combination of the two giant pharmacy chains had been under intense scrutiny from Federal Trade Commission and its fate was far from certain, the decision to end the old deal sent Rite Aid shares down 23% in premarket trading Thursday. Walgreens jumped 4.4%.

Rite Aid, in a statement, said it received feedback from the FTC "that led the company to believe that the parties would not have obtained FTC clearance to consummate the merger."

This is the second time Walgreens has altered its plan to buy Rite Aid stores. The first agreement announced in 2015 was for $9 a share, or $9.4 billion. A revised acquisition deal announced in January valued the deal at $6.50 to $7, or between $6.84 billion and $7.37 billion, depending on how many store changed hands.

Under the current plan, it is no longer purchasing Rite Aid at all, but merely acquiring stores and other assets from the company. Rite Aid will receive a termination fee of $325 million in addition to the purchase price.

Walgreens had been waiting for months to see whether the FTC would try to block the planned acquisition of Rite Aid, which would have vaulted the combined company past CVS Health Corp. to become the leading drugstore chain by number of stores. In May, Walgreens moved to force a U.S. decision on the matter, which was due by July 7.

The original agreement would have been for about 3,336 stores "making this agreement about one-third smaller and more likely to pass regulatory scrutiny in our view," Leerink analyst David Larsen said in a note to clients.

The old deal also included a plan to sell as many as 1,200 Rite Aid locations to regional chain Fred's Inc. Fred's fell 19% to $10 in early trading.

"This is a disappointing outcome," said Michael Bloom, Fred's chief executive officer, in a statement. "However, the termination of the transaction has no impact on the company's transformation strategy or our ability to execute."

Walgreens said in a statement that it will begin acquiring the Rite Aid stores and related assets over a period of approximately six months, and intends to convert the stores to the Walgreens brand over time.

The FTC will end its review of the previous merger agreement and start an investigation of the new deal for stores and and assets to determine whether competition is harmed.

Most Popular
In this article: